DPW Holdings - Corporate Logo Dark Blue Lettering Only 01052018.jpg
DPW Holdings Terminates the At Market Issuance Sales Agreement
September 13, 2018 06:30 ET | DPW Holdings, Inc.
Newport Beach, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), announced that it has sent a notice to H.C....
ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference
September 04, 2018 02:47 ET | ASLAN Pharmaceuticals Limited
SINGAPORE, Sept. 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics to Present at FB Riley and HC Wainwright Sept 2018 Healthcare Conferences in NYC (NY)
September 02, 2018 13:19 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Sept. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will be participating in upcoming...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Present at Upcoming Investor Conferences
August 29, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics to Present at H.C. Wainwright Global Lifesciences Conference 04/09/18
April 04, 2018 17:46 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento"), announced today that it will present at the H.C. Wainwright Global Lifesciences conference on...
XOMA royalty-2c.png
XOMA to Present at the H.C. Wainwright Global Life Sciences Conference
April 03, 2018 07:00 ET | XOMA Corporation
EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal,...